Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Antonio Ruı́z-Villaespesa"'
Autor:
Ana B. Fernández-Martínez, Antonio Ruı́z-Villaespesa, Pedro L. Valenzuela, Ana M. Bajo, Eva Vacas, Ana Valdehita, Juan C. Prieto, M. Isabel Arenas, María J. Carmena
Publikováno v:
Peptides. 31:2035-2045
Vasoactive intestinal peptide (VIP) and its receptors (VPACs) are involved in proliferation, survival, and differentiation in human breast cancer cells. Its mechanism of action is traditionally thought to be through specific plasma membrane receptors
Autor:
J Cortés, Juan C. Prieto, Antonio Ruı́z-Villaespesa, M.Olga Garcı́a-Fernández, María J. Carmena, Guillermo Bodega
Publikováno v:
Cancer Letters. 205:189-195
Pituitary adenylate cyclase-activating peptide (PACAP) is involved in various biological processes including cell growth, proliferation and differentiation. Here, we demonstrate for the first time the presence of both PACAP mRNA and PACAP immunoreact
Autor:
Manuel Sánchez-Chapado, Antonio Ruı́z-Villaespesa, R.M. Solano, María J. Carmena, Guillermo Bodega, M.Olga Garcı́a-Fernández, Rebeca Busto, Juan C. Prieto
Publikováno v:
Peptides. 24:893-902
Vasoactive intestinal peptide (VIP) is involved in prostate cell proliferation and function. VIP and pituitary adenylate cyclase-activating peptide (PACAP) are similarly recognized by VPAC(1)/VPAC(2) receptors whereas PACAP binds with higher affinity
Autor:
M.Olga Garcı́a-Fernández, Antonio Ruı́z-Villaespesa, R.M. Solano, Juan C. Prieto, Manuel Sánchez-Chapado, María J. Carmena
Publikováno v:
Journal of Urology. 166:2512-2517
Purpose: Because of increasing interest in G protein regulation of cell growth, differentiation and oncogenesis, we studied the functionality and expression of different G protein subunits in human prostate adenocarcinoma.Materials and Methods: Surgi
Autor:
Antonio Ruı́z-Villaespesa, J Cortés, Guillermo Bodega, Juan C. Prieto, María J. Carmena, Molga García-Fernández, Beatriz Collado
Publikováno v:
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 20(6)
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP) bind similarly to VPAC1 and VPAC2 receptors, whereas PACAP binds with higher affinity than VIP to PAC1 receptors. Here we demonstrate by different approach
Autor:
María J. Carmena, Guillermo Bodega, Antonio Ruı́z-Villaespesa, Manuel Sánchez-Chapado, R.M. Solano, Juan C. Prieto, M.Olga Garcı́a-Fernández
Publikováno v:
Regulatory peptides. 110(1)
The presence, expression and distribution of pituitary adenylate cyclase-activating peptide (PACAP) in human prostate cancer and healthy tissue were investigated by means of biochemical and morphological procedures. Reverse transcription-polymerase c
Autor:
Jozsef L. Varga, Juan C. Prieto, Andrew V. Schally, Ana B. Fernández-Martínez, Antonio Ruı́z-Villaespesa, Beatriz Collado, Ana M. Bajo, Manuel Sánchez-Chapado, María J. Carmena
Publikováno v:
Scopus-Elsevier
ResearcherID
ResearcherID
Vasoactive intestinal peptide (VIP) functions as a mitogenic agent in the human prostate gland acting by autocrine/paracrine mechanisms. Here we extend knowledge on the VIP system (expression of VIP and VIP receptors, functionality of VIP receptors)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a9d92f1d0dc949973f81d595ec9f8a9
http://www.scopus.com/inward/record.url?eid=2-s2.0-22344451194&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-22344451194&partnerID=MN8TOARS